Logan Doraisamy, PhD

Dr. Loganathan Doraisamy has been developing magnetic resonance-based biosensor technologies and optical biosensors since 2003 for GE, hospital labs, universities and US Government agencies.

He has expertise in several Magnetic Resonance technologies, and applied them for CBRNE sensing. He has experience in nano-bio technologies, biomarker detection, microfluidics and sequencing technologies for healthcare and biodefense. He has led collaborations among biotech industry, university researchers, clinical and government laboratories, US government funding agencies, private investors and customers, enabling R&D, product development and, commercialization.

‍